What is L‑methylfolate calcium?

What is L-methylfolate Calcium?

L-methylfolate calcium is the bioactive, calcium salt form of folate (5-methyltetrahydrofolate) that serves as a medical food or dietary supplement, representing the predominant form of folate naturally found in circulation and the only form normally transported into peripheral tissues for cellular metabolism. 1, 2

Chemical and Biological Properties

L-methylfolate calcium is a proprietary biologically active folate derived from food sources that differs fundamentally from synthetic folic acid 1:

• It is the primary circulating form of folate in human blood and the metabolically active form that cells directly utilize, unlike folic acid which requires enzymatic reduction to become active 2
• It bypasses the need for dihydrofolate reductase enzyme activity, making it particularly advantageous for individuals with genetic polymorphisms (especially MTHFR C677T variants) that impair folic acid metabolism 3, 4
• The calcium salt formulation provides stability required for pharmaceutical and supplement use while maintaining bioavailability 2

Regulatory Classification

L-methylfolate calcium occupies a unique regulatory position:

• In the United States, it is classified as a prescription medical food for clinical dietary management of metabolic imbalances, particularly those associated with depression, schizophrenia, and diabetic peripheral neuropathy 1
• It is not an FDA Orange Book product (not classified as a conventional drug) but requires medical supervision 1
• In Europe, it has been approved as a source of folate for addition to infant formula, follow-on formula, baby food, processed cereal-based food, fortified foods, and food supplements 5

Bioavailability and Equivalence

The bioavailability profile distinguishes L-methylfolate from folic acid:

• At doses below 400 μg/day, L-methylfolate has comparable bioavailability to folic acid with a dietary folate equivalent (DFE) conversion factor of 1.7 relative to natural food folate 6
• At doses ≥400 μg/day, L-methylfolate demonstrates superior bioavailability to folic acid with a DFE conversion factor of 2.0 6
• Equimolar doses of L-methylfolate and folic acid show comparable physiological activity in improving folate status as measured by blood folate concentrations and plasma homocysteine levels 2

Clinical Applications

L-methylfolate calcium has several established and emerging therapeutic uses:

Neuropsychiatric Conditions

• As adjunctive therapy for major depressive disorder at 15 mg/day, particularly benefiting patients with BMI ≥30 kg/m² and elevated inflammatory biomarkers 7
• For dietary management of metabolic imbalances in depression and schizophrenia 1

Diabetic Peripheral Neuropathy

• Addresses underlying pathophysiology of DPN by facilitating synthesis of tetrahydrobiopterin (BH4), a critical coenzyme in neurotransmitter production, extending beyond symptomatic relief 3

Homocysteine Reduction

• Effectively lowers elevated homocysteine levels, with particular benefit in individuals carrying MTHFR 677TT genotype who show significantly greater reductions compared to other genotypes 4

Neural Tube Defect Prevention

While standard folic acid recommendations remain primary 8, L-methylfolate represents an alternative for women who may have impaired folic acid metabolism.

Safety Profile

The safety data for L-methylfolate calcium is robust:

• Non-genotoxic in both in vitro and in vivo studies, with no mutagenic effects or chromosomal aberrations 9
• No observed adverse effect level (NOAEL) of 400 mg/kg body weight/day in 13-week subchronic toxicity studies in rats 9
• Not teratogenic or embryotoxic in prenatal developmental toxicity studies 9
• Safe for use in infants and young children when added to infant formula and baby foods at proposed use levels 5
• Minimal adverse effects in clinical use, notably lacking the weight gain, metabolic perturbations, and movement disorders associated with other adjunctive treatments like atypical antipsychotics 7

Advantages Over Folic Acid

L-methylfolate calcium offers several theoretical and practical advantages:

• Reduced risk of masking vitamin B12 deficiency compared to high-dose folic acid, as it may not correct the hematological manifestations while allowing neurological complications to progress 2
• Reduced interaction with dihydrofolate reductase-inhibiting drugs (such as methotrexate) since it doesn't require this enzyme for activation 2
• Direct cellular uptake without metabolic conversion, making it immediately bioavailable for folate-dependent metabolic processes 2

Important Caveats

• The upper limit (UL) for folic acid of 1 mg/day was established to avoid delayed diagnosis of vitamin B12 deficiency; this consideration applies to all folate forms including L-methylfolate 8
• Patients being evaluated for folate deficiency should also be evaluated for cobalamin deficiency, as deficiency in both vitamins causes megaloblastic anemia, and treating folate deficiency alone may worsen neurological manifestations of B12 deficiency 8
• The influence of different cations (calcium vs. glucosamine) on bioavailability is likely within the margin of error, allowing the same DFE equations to apply across different salt forms 6